Cargando…
Combined treatments with AZD5363, AZD8542, curcumin or resveratrol induce death of human glioblastoma cells by suppressing the PI3K/AKT and SHH signaling pathways
Glioblastoma (GBM) is a very aggressive tumor that presents vascularization, necrosis and is resistant to chemotherapy and radiotherapy. Current treatments are not effective eradicating GBM, thus, there is an urgent need to develop novel therapeutic strategies against GBM. AZD5363, AZD8542, curcumin...
Autores principales: | Mejía-Rodríguez, Rosalinda, Romero-Trejo, Daniel, González, Rosa O., Segovia, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876780/ https://www.ncbi.nlm.nih.gov/pubmed/36714540 http://dx.doi.org/10.1016/j.bbrep.2023.101430 |
Ejemplares similares
-
A combination of AZD5363 and FH5363 induces lethal autophagy in transformed hepatocytes
por: Patra, Tapas, et al.
Publicado: (2020) -
Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors
por: Tamura, Kenji, et al.
Publicado: (2016) -
T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma
por: Zhong, Sheng, et al.
Publicado: (2019) -
A Phase 1, open-label, multicentre study to compare the capsule and tablet formulations of AZD5363 and explore the effect of food on the pharmacokinetic exposure, safety and tolerability of AZD5363 in patients with advanced solid malignancies: OAK
por: Dean, Emma, et al.
Publicado: (2018) -
AZD5363 Inhibits Inflammatory Synergy between Interleukin-17 and Insulin/Insulin-Like Growth Factor 1
por: Chen, Chong, et al.
Publicado: (2014)